Selank is synthetic tuftsin-derived heptapeptide. Researchers examine it in relation to anxiety-related behaviour, neuroimmune signalling and cognition models.

Researchers study anxiety-related behaviour, stress responses and possible effects on attention or memory. Evidence is limited and it is not an authorised treatment in the UK.

Proposed to modulate GABAergic, serotonergic and immune gene-expression pathways, though a definitive human mechanism is unconfirmed.

Small regional human studies and preclinical literature exist; large independently replicated trials are lacking.

No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.